Study lays groundwork for refractory cutaneous lupus treatment algorithms

SCOTTSDALE, ARIZ. – Thalidomide, methotrexate, dapsone, and belimumab may be the best treatment alternatives for cutaneous lupus erythematosus that is refractory to antimalarials, based on reviews of 15 years of medical records from three large tertiary care centers. The study is the largest so...
Source: Skin and Allergy News - Category: Dermatology Source Type: news